search
Back to results

Race, Menopause and Metabolism After Exercise and Diet

Primary Purpose

Obesity, Insulin Resistance, Sedentary Lifestyle

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Diet modification
Aerobic exercise
Sponsored by
National Institute on Aging (NIA)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Exercise, Obesity, Insulin Sensitivity

Eligibility Criteria

45 Years - 80 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Female
  • 45-80 yrs of age
  • Non-smoking for one year
  • BMI greater than 25 kg/m2 and less than 50 kg/m2
  • Menopause over 1 year
  • Caucasian or African American ethnicity

Exclusion Criteria:

Both groups

  • Currently being treated for active cancer
  • Type 1 diabetes; insulin treatment; poorly controlled (fasting blood sugar over 160 mg/dl)
  • Allergic to lidocaine or heparin
  • Untreated dyslipidemia, receiving triglyceride-lowering meds
  • Other systemic disorders that are not medically treated and stable
  • Taking beta-blockers, oral steroids, warfarin or any other medications interfering with fat/muscle metabolism that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior)
  • Abnormal liver or renal function; chronic pulmonary disease (on supplemental oxygen); anemia
  • MMSE (Mini-Mental State Examination) below 24, dementia or unstable clinical depression by exam
  • Women of ethnicity other than Caucasian or African American
  • Symptomatic heart disease, coronary artery disease, congestive heart failure, or uncontrolled hypertension unless medically stabilized
  • Abnormal response to exercise test (chest pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising blood pressure above 240/120mm Hg, or other contraindications to exercise)

Exercise plus weight loss group only

  • Medical history of CVD (cardiovascular disease) with symptoms limiting ability to exercise
  • Physical impairment limiting normal activity
  • Aerobically trained with VO2max greater than 2 SD (standard deviation) above age-adjusted mean

Sites / Locations

  • University of Maryland, VAMC

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

1

2

Arm Description

Weight loss

Exercise plus weight loss

Outcomes

Primary Outcome Measures

Glucose Clamp
Fat biopsy

Secondary Outcome Measures

Full Information

First Posted
April 15, 2009
Last Updated
January 11, 2010
Sponsor
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00882141
Brief Title
Race, Menopause and Metabolism After Exercise and Diet
Official Title
Menopause, Genes and Metabolism After Weight Loss and Exercise
Study Type
Interventional

2. Study Status

Record Verification Date
January 2010
Overall Recruitment Status
Completed
Study Start Date
March 2002 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
December 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute on Aging (NIA)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to test the hypotheses that there are ethnic and genetic differences in the mechanisms and magnitude by which hypocaloric weight loss and aerobic exercise affect body composition, glucose, lipid, muscle and adipose tissue metabolism in overweight, insulin resistant postmenopausal women. This will be tested in a trial comparing the effects of weight loss vs. aerobic exercise plus weight loss on glucose, lipid, fat and muscle metabolism in overweight African American and Caucasian postmenopausal women.
Detailed Description
The findings of this study will also determine whether there are racial differences in the whole body and cellular mechanisms by which aerobic exercise training and weight loss affect glucose, lipid, fat and muscle metabolism in African-American vs. Caucasian postmenopausal women. The results also may provide a rationale for targeting specific populations of women who might improve glucose, lipid, fat and muscle metabolism more from the addition of exercise to dietary restriction than weight loss alone to reduce their risk for type 2 diabetes and cardiovascular disease. The study protocol consists of the following phases: Phase 1-Recruitment and screening. Phase 2-Weight and dietary stabilization for 4-6 weeks, where participants are taught the principles of the American Heart Association "Heart Healthy" diet and provided food to consume prior to testing. Phase 3-Participants will undergo research testing including glucose clamp and fat biopsy. Phase 4-Participants select either weight loss only, or exercise plus weight loss. The behavior diet modification weight loss sessions are held by a registered dietitian for 1 hour once a week for 6-9 months where the recommended caloric intake for each participant is adjusted by the dietitian to elicit a weight loss of approximately 0.2-0.4 kg per week. In addition to the weight loss sessions, participants who select the aerobic exercise plus weight loss intervention will exercise at the Baltimore Geriatric Research Education and Clinical Center (GRECC) exercise facility 3 times a week for 6-9 months using treadmills and other aerobic exercise equipment. Exercise sessions begin at low levels of VO2max (maximal oxygen consumption) and progress in duration and intensity until the participant is able to exercise at more than 75% VO2max for 45 minutes. Phase 5-Following the 6-9 months of long-term weight loss or exercise plus weight loss, all participants will undergo long-term metabolic testing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Insulin Resistance, Sedentary Lifestyle
Keywords
Exercise, Obesity, Insulin Sensitivity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
103 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Weight loss
Arm Title
2
Arm Type
Experimental
Arm Description
Exercise plus weight loss
Intervention Type
Behavioral
Intervention Name(s)
Diet modification
Other Intervention Name(s)
American Heart Association "Heart Healthy" diet
Intervention Description
Weight loss sessions are held by a registered dietitian for 1 hour once a week for 6-9 months; recommended caloric intake to elicit a weight loss of approximately 0.2-0.4 kg per week
Intervention Type
Behavioral
Intervention Name(s)
Aerobic exercise
Intervention Description
Treadmills and other aerobic exercise equipment 3 times a week for 6-9 months, beginning at low levels of VO2max and progressing in duration and intensity to more than 75% VO2max for 45 minutes
Primary Outcome Measure Information:
Title
Glucose Clamp
Time Frame
At 4-6 weeks
Title
Fat biopsy
Time Frame
At 4-6 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Female 45-80 yrs of age Non-smoking for one year BMI greater than 25 kg/m2 and less than 50 kg/m2 Menopause over 1 year Caucasian or African American ethnicity Exclusion Criteria: Both groups Currently being treated for active cancer Type 1 diabetes; insulin treatment; poorly controlled (fasting blood sugar over 160 mg/dl) Allergic to lidocaine or heparin Untreated dyslipidemia, receiving triglyceride-lowering meds Other systemic disorders that are not medically treated and stable Taking beta-blockers, oral steroids, warfarin or any other medications interfering with fat/muscle metabolism that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior) Abnormal liver or renal function; chronic pulmonary disease (on supplemental oxygen); anemia MMSE (Mini-Mental State Examination) below 24, dementia or unstable clinical depression by exam Women of ethnicity other than Caucasian or African American Symptomatic heart disease, coronary artery disease, congestive heart failure, or uncontrolled hypertension unless medically stabilized Abnormal response to exercise test (chest pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising blood pressure above 240/120mm Hg, or other contraindications to exercise) Exercise plus weight loss group only Medical history of CVD (cardiovascular disease) with symptoms limiting ability to exercise Physical impairment limiting normal activity Aerobically trained with VO2max greater than 2 SD (standard deviation) above age-adjusted mean
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alice S. Ryan, PhD
Organizational Affiliation
University of Maryland, VA Research Service
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Andrew P. Goldberg, MD
Organizational Affiliation
University of Maryland, VA Research Service
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Maryland, VAMC
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
20705
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
11231984
Citation
Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP. Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women. J Clin Endocrinol Metab. 2001 Jan;86(1):97-103. doi: 10.1210/jcem.86.1.7147.
Results Reference
background
PubMed Identifier
12006632
Citation
Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Obes Res. 2002 May;10(5):336-44. doi: 10.1038/oby.2002.47.
Results Reference
background
PubMed Identifier
12586858
Citation
Nicklas BJ, Dennis KE, Berman DM, Sorkin J, Ryan AS, Goldberg AP. Lifestyle intervention of hypocaloric dieting and walking reduces abdominal obesity and improves coronary heart disease risk factors in obese, postmenopausal, African-American and Caucasian women. J Gerontol A Biol Sci Med Sci. 2003 Feb;58(2):181-9. doi: 10.1093/gerona/58.2.m181.
Results Reference
background
PubMed Identifier
16861612
Citation
Ryan AS, Nicklas BJ, Berman DM. Aerobic exercise is necessary to improve glucose utilization with moderate weight loss in women. Obesity (Silver Spring). 2006 Jun;14(6):1064-72. doi: 10.1038/oby.2006.122.
Results Reference
background
PubMed Identifier
29071802
Citation
Ryan AS, Serra MC, Goldberg AP. Metabolic Benefits of Prior Weight Loss with and without Exercise on Subsequent 6-Month Weight Regain. Obesity (Silver Spring). 2018 Jan;26(1):37-44. doi: 10.1002/oby.22032. Epub 2017 Oct 25.
Results Reference
derived
PubMed Identifier
28547918
Citation
Ortmeyer HK, Goldberg AP, Ryan AS. Exercise with weight loss improves adipose tissue and skeletal muscle markers of fatty acid metabolism in postmenopausal women. Obesity (Silver Spring). 2017 Jul;25(7):1246-1253. doi: 10.1002/oby.21877. Epub 2017 May 26.
Results Reference
derived
PubMed Identifier
24929893
Citation
Ge S, Ryan AS. Zinc-alpha2-glycoprotein expression in adipose tissue of obese postmenopausal women before and after weight loss and exercise + weight loss. Metabolism. 2014 Aug;63(8):995-9. doi: 10.1016/j.metabol.2014.04.013. Epub 2014 May 4.
Results Reference
derived
PubMed Identifier
24635342
Citation
Ryan AS, Ge S, Blumenthal JB, Serra MC, Prior SJ, Goldberg AP. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J Am Geriatr Soc. 2014 Apr;62(4):607-14. doi: 10.1111/jgs.12749. Epub 2014 Mar 17.
Results Reference
derived
PubMed Identifier
24595633
Citation
Prior SJ, Blumenthal JB, Katzel LI, Goldberg AP, Ryan AS. Increased skeletal muscle capillarization after aerobic exercise training and weight loss improves insulin sensitivity in adults with IGT. Diabetes Care. 2014 May;37(5):1469-75. doi: 10.2337/dc13-2358. Epub 2014 Mar 4.
Results Reference
derived
PubMed Identifier
24311467
Citation
Yang RZ, Blumenthal JB, Glynn NM, Lee MJ, Goldberg AP, Gong DW, Ryan AS. Decrease of circulating SAA is correlated with reduction of abdominal SAA secretion during weight loss. Obesity (Silver Spring). 2014 Apr;22(4):1085-90. doi: 10.1002/oby.20657. Epub 2013 Dec 6.
Results Reference
derived
PubMed Identifier
23687104
Citation
Ryan AS, Li G, Blumenthal JB, Ortmeyer HK. Aerobic exercise + weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults. Obesity (Silver Spring). 2013 Jul;21(7):1350-6. doi: 10.1002/oby.20216. Epub 2013 May 19.
Results Reference
derived

Learn more about this trial

Race, Menopause and Metabolism After Exercise and Diet

We'll reach out to this number within 24 hrs